ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 024,58
0,35%
Dow Jones
38 852,27
0,46%
DAX
18 310,21
0,76%
Brent Oil
82,87
-0,72%
Bitcoin
64 073,44
1,44%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Aoxing Pharmaceutical Company New (delisted) (AXN)

  7. Aoxing Pharmaceutical Company New (delisted) (AXN) Actualités

AXN

Aoxing Pharmaceutical Company New (delisted) (AXN)

Aoxing Pharmaceutical Company New (delisted)
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:AXN
DateHeureSourceTitreSymboleSociété
17/10/201719h28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
06/10/201722h17Edgar (US Regulatory)(25)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
06/10/201712h03Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
29/09/201712h04Edgar (US Regulatory)Withdrawal of Registration Statement (ammendment) (aw)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
28/09/201712h04Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
27/09/201721h10Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
26/09/201717h03Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
25/09/201712h02Edgar (US Regulatory)Current Report Filing (8-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
15/05/201714h39Edgar (US Regulatory)Quarterly Report (10-q)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
11/05/201716h21Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
11/05/201716h20Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
17/02/201718h34Edgar (US Regulatory)Amended Quarterly Report (10-q/a)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
05/10/201622h33Edgar (US Regulatory)Annual Report (10-k)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
08/02/201614h30PR Newswire (US)Aoxing Pharmaceuticals Q2 Revenue Up 27%; Net Income $2.1 Million, Up 265%AMEX:AXNAoxing Pharmaceutical Company New (delisted)
01/02/201614h30PR Newswire (US)Aoxing Pharma Appoints Dr. James Chen as Chief Financial OfficerAMEX:AXNAoxing Pharmaceutical Company New (delisted)
10/12/201514h30PR Newswire (US)Aoxing Pharma Selected to Supply Zhongtongan to the Insurance System for the City of ShanghaiAMEX:AXNAoxing Pharmaceutical Company New (delisted)
04/12/201514h30PR Newswire (US)Aoxing Pharma Announces Opening Of Government Funded Drug Research CenterAMEX:AXNAoxing Pharmaceutical Company New (delisted)
04/12/201514h00PR Newswire (US)Aoxing Pharma Announces Resignation of CFOAMEX:AXNAoxing Pharmaceutical Company New (delisted)
03/12/201516h38PR Newswire (US)SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aoxing Pharmaceutical Company, Inc.AMEX:AXNAoxing Pharmaceutical Company New (delisted)
03/12/201500h27PR Newswire (US)SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aoxing Pharmaceutical, Inc. - AXNAMEX:AXNAoxing Pharmaceutical Company New (delisted)
13/11/201514h30PR Newswire (US)Aoxing Pharmaceuticals Q1 Revenue Up 92 Percent; Net Income Of $1.35 MillionAMEX:AXNAoxing Pharmaceutical Company New (delisted)
28/09/201522h14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
28/07/201515h10PR Newswire (US)Drug Manufacturers - Major Stocks on the Move -- GlaxoSmithKline, Sanofi, Aerie Pharma, TherapeuticsMD, and Aoxing PharmaAMEX:AXNAoxing Pharmaceutical Company New (delisted)
22/06/201523h15Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
09/02/201520h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
09/02/201519h58Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:AXNAoxing Pharmaceutical Company New (delisted)
17/06/201402h26MarketwiredAoxing Pharmaceutical Company, Inc. Receives Notice of Extension From NYSEMKT LLCAMEX:AXNAoxing Pharmaceutical Company New (delisted)
14/05/201423h45MarketwiredAoxing Pharmaceutical Company, Inc. Announces Financial Results for Third Quarter of 2014 Fiscal YearAMEX:AXNAoxing Pharmaceutical Company New (delisted)
04/03/201423h30MarketwiredAoxing Pharmaceutical Company, Inc. Receives Notice of Extension and Additional Notice of Noncompliance From NYSEMKT LLCAMEX:AXNAoxing Pharmaceutical Company New (delisted)
19/02/201418h15MarketwiredAoxing Pharmaceutical Company, Inc. Announces Financial Results for Second Quarter of 2014 Fiscal YearAMEX:AXNAoxing Pharmaceutical Company New (delisted)
 Showing the most relevant articles for your search:AMEX:AXN

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
NASDAQ
GOOGL
Alphabet
EU
ACA
Credit Agricole
NASDAQ
MSFT
Microsoft
EU
BEL20
Bel 20
EU
SGO
Cie de SaintGobain
COIN
ETHUSD
Ethereum
EU
CAP
Capgemini
EU
EN
Bouygues
NASDAQ
NVDA
NVIDIA
EU
RNO
Renault
EU
ML
Michelin
FTSE
UKX
FTSE 100
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés